Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Abbott Laboratories
(NY:
ABT
)
102.30
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Apr 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
578
Open
102.30
Bid (Size)
102.35 (100)
Ask (Size)
102.98 (100)
Prev. Close
102.30
Today's Range
102.30 - 102.30
52wk Range
100.88 - 139.06
Shares Outstanding
1,750,942,289
Dividend Yield
2.46%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Decacorn of Performance: Whoop Secures $10.1 Billion Valuation in Landmark Series G Led by TPG
April 06, 2026
In a move that cements the "human performance" category as a pillar of the future economy, Whoop has officially closed a massive $575 million Series G funding round, catapulting the wearable technology...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Initial Public Offering
Robotic Revolution in the Electrophysiology Lab: FDA Clears Stereotaxis Synchrony System
April 06, 2026
ST. LOUIS – April 6, 2026 – In a milestone that signals a paradigm shift for cardiac care, Stereotaxis (NYSE American: STXS) has received FDA 510(k) clearance for its Synchrony™ System. The approval...
Via
MarketMinute
Topics
Artificial Intelligence
Performance
YTD
-17.6%
-17.6%
1 Month
-9.2%
-9.2%
3 Month
-19.1%
-19.1%
6 Month
-23.5%
-23.5%
1 Year
-18.1%
-18.1%
More News
Read More
Stereotaxis Secures FDA Clearance for Synchrony™ System, Completing Its Vision for the Robotic "Digital Cockpit"
April 06, 2026
Via
MarketMinute
Abbott Laboratories (NYSE:ABT) Stands Out as a Dependable Dividend Stock
↗
April 01, 2026
Via
Chartmill
The “New BD”: A Deep-Dive Research Report on Becton, Dickinson and Company (BDX) in 2026
April 03, 2026
Via
Finterra
Topics
Artificial Intelligence
The Martha Transformation: A Deep Dive into Medtronic’s 2026 Pivot
April 03, 2026
Via
Finterra
Topics
Artificial Intelligence
Initial Public Offering
Product Recall
1 Healthcare Stock on Our Watchlist and 2 We Find Risky
April 03, 2026
Via
StockStory
Abbott Laboratories (NYSE:ABT) Passes the 'Caviar Cruise' Quality Investing Screen
↗
March 25, 2026
Via
Chartmill
Wall Street's Advisory Windfall: Goldman Sachs and JPMorgan Lead the M&A Renaissance
April 02, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Best Healthcare Stocks to Buy Right Now for Long-Term Growth
↗
April 01, 2026
Via
The Motley Fool
The Great Rebound: US Megadeals Surge 319% as Corporate Consolidation Returns with a Vengeance
April 01, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
The Evolution of a MedTech Giant: A Deep Dive into Becton, Dickinson and Company (BDX)
April 01, 2026
Via
Finterra
Topics
Economy
Lawsuit
Product Recall
The Medtronic Transformation: A Deep Dive into the Future of a MedTech Titan
April 01, 2026
Via
Finterra
Topics
Artificial Intelligence
Economy
Initial Public Offering
Deep Dive: Boston Scientific (BSX) and the New Era of Medical Device Dominance
March 31, 2026
Via
Finterra
Topics
Lawsuit
Product Recall
This Top ETF Recently Added a Healthy Dose of These High-Yielding Dividend Stocks
↗
March 30, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
The Great Divergence: Q1 2026 M&A Hits Record $813.3 Billion Amidst "K-Shaped" Recovery
March 24, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Abbott Laboratories Finalizes $21 Billion Acquisition of Exact Sciences, Redefining the Future of Cancer Diagnostics
March 23, 2026
Via
MarketMinute
Topics
Supply Chain
2 Defensive Healthcare Stocks to Buy Right Now
↗
March 22, 2026
Via
The Motley Fool
Topics
Artificial Intelligence
Economy
The Record-Breaking M&A Renaissance of 2026: Why Deal Values are Soaring as Volume Dips
March 19, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Workforce
1 Magnificent Dividend Stock Down 22% That's a Screaming Buy Right Now
↗
March 19, 2026
Via
The Motley Fool
The Best Dividend Stocks to Buy and Hold Forever
↗
March 12, 2026
Via
The Motley Fool
Topics
Intellectual Property
Q4 Earnings Highs And Lows: Abbott Laboratories (NYSE:ABT) Vs The Rest Of The Medical Devices & Supplies - Diversified Stocks
March 11, 2026
Via
StockStory
Macroeconomic Headwinds and Shifting Demand Force Healthcare Giants to Trim 2026 Outlooks
March 09, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
2 Profitable Stocks on Our Watchlist and 1 We Avoid
March 09, 2026
Via
StockStory
The Return of the Titans: M&A Volume Set to Surge 20% in 2026 Amidst "Animal Spirits"
March 04, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
World Trade
Frequently Asked Questions
Is Abbott Laboratories publicly traded?
Yes, Abbott Laboratories is publicly traded.
What exchange does Abbott Laboratories trade on?
Abbott Laboratories trades on the New York Stock Exchange
What is the ticker symbol for Abbott Laboratories?
The ticker symbol for Abbott Laboratories is ABT on the New York Stock Exchange
What is the current price of Abbott Laboratories?
The current price of Abbott Laboratories is 102.30
When was Abbott Laboratories last traded?
The last trade of Abbott Laboratories was at 04/06/26 07:00 PM ET
What is the market capitalization of Abbott Laboratories?
The market capitalization of Abbott Laboratories is 179.12B
How many shares of Abbott Laboratories are outstanding?
Abbott Laboratories has 179B shares outstanding.
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.